PT1427748E - 17alfa-hidroxi-14beta-esteróides com efeito hormonal - Google Patents

17alfa-hidroxi-14beta-esteróides com efeito hormonal Download PDF

Info

Publication number
PT1427748E
PT1427748E PT02777036T PT02777036T PT1427748E PT 1427748 E PT1427748 E PT 1427748E PT 02777036 T PT02777036 T PT 02777036T PT 02777036 T PT02777036 T PT 02777036T PT 1427748 E PT1427748 E PT 1427748E
Authority
PT
Portugal
Prior art keywords
14beta
17alpha
steroids
hydroxy
hormonal effect
Prior art date
Application number
PT02777036T
Other languages
English (en)
Portuguese (pt)
Inventor
Dirk Leysen
Jaap Van Der Louw
Marcel Evert De Gooijer
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1427748(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of PT1427748E publication Critical patent/PT1427748E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT02777036T 2001-09-12 2002-09-06 17alfa-hidroxi-14beta-esteróides com efeito hormonal PT1427748E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12

Publications (1)

Publication Number Publication Date
PT1427748E true PT1427748E (pt) 2008-08-27

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02777036T PT1427748E (pt) 2001-09-12 2002-09-06 17alfa-hidroxi-14beta-esteróides com efeito hormonal

Country Status (28)

Country Link
US (1) US7169769B2 (enExample)
EP (1) EP1427748B1 (enExample)
JP (1) JP4471653B2 (enExample)
KR (1) KR100940054B1 (enExample)
CN (1) CN1257913C (enExample)
AR (1) AR036462A1 (enExample)
AT (1) ATE395352T1 (enExample)
AU (1) AU2002339536B2 (enExample)
BR (1) BR0212409A (enExample)
CA (1) CA2505575C (enExample)
CY (1) CY1108152T1 (enExample)
DE (1) DE60226623D1 (enExample)
DK (1) DK1427748T3 (enExample)
EC (1) ECSP045012A (enExample)
ES (1) ES2305306T3 (enExample)
HR (1) HRP20040193A2 (enExample)
HU (1) HUP0402139A3 (enExample)
IL (2) IL160451A0 (enExample)
IS (1) IS2555B (enExample)
MX (1) MXPA04002418A (enExample)
NO (1) NO326624B1 (enExample)
NZ (1) NZ531487A (enExample)
PL (1) PL207493B1 (enExample)
PT (1) PT1427748E (enExample)
RU (1) RU2294332C2 (enExample)
TW (1) TWI221154B (enExample)
WO (1) WO2003022864A1 (enExample)
ZA (1) ZA200401992B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
AU4299301A (en) * 2000-02-29 2001-09-12 National University Of Singapore, The A method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
WO2003022864A1 (en) 2003-03-20
HUP0402139A3 (en) 2012-12-28
JP4471653B2 (ja) 2010-06-02
US20040259849A1 (en) 2004-12-23
ATE395352T1 (de) 2008-05-15
MXPA04002418A (es) 2004-07-30
CY1108152T1 (el) 2014-02-12
BR0212409A (pt) 2004-08-03
NO20041010L (no) 2004-03-10
AU2002339536B2 (en) 2008-04-24
KR20040039346A (ko) 2004-05-10
NZ531487A (en) 2005-08-26
TWI221154B (en) 2004-09-21
EP1427748A1 (en) 2004-06-16
PL207493B1 (pl) 2010-12-31
HRP20040193A2 (en) 2004-08-31
ECSP045012A (es) 2004-09-27
ZA200401992B (en) 2005-04-21
AR036462A1 (es) 2004-09-08
CA2505575A1 (en) 2003-03-20
CN1257913C (zh) 2006-05-31
PL368727A1 (en) 2005-04-04
CA2505575C (en) 2010-01-26
RU2004110934A (ru) 2005-08-20
IS2555B (is) 2009-10-15
IL160451A (en) 2009-11-18
DK1427748T3 (da) 2008-09-08
CN1553917A (zh) 2004-12-08
DE60226623D1 (de) 2008-06-26
US7169769B2 (en) 2007-01-30
IL160451A0 (en) 2004-07-25
ES2305306T3 (es) 2008-11-01
NO326624B1 (no) 2009-01-19
KR100940054B1 (ko) 2010-02-04
JP2005505566A (ja) 2005-02-24
RU2294332C2 (ru) 2007-02-27
EP1427748B1 (en) 2008-05-14
IS7165A (is) 2004-02-26
HK1063637A1 (en) 2005-01-07
HUP0402139A2 (hu) 2005-02-28

Similar Documents

Publication Publication Date Title
DE60217162D1 (en) Tetrafluorethen-perfluorbutylethen-copolymer
DE50202400D1 (en) Baw-resonator
DE60237965D1 (en) Metalloproteinaseinhibitoren
DE60217478D1 (en) Sychrongleichrichter
DE60231477D1 (en) Imidazolderivate
DE60141362D1 (en) Ösophagus-stoma-knopf
DE60218514D1 (en) Polyolefin-kunststoffrohre
DE50202633D1 (en) Ophthalmoskop
EP1417203A4 (en) S-6-HYDROXY-BUSPIRONE
AU2002360430A8 (en) 14-methyl-epothilones
GB2392916B (en) Deicing
DE60226167D1 (en) Computersystem-e/a-knoten
DE50203686D1 (en) Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate
DE50214962D1 (en) Heterocyclylarylsulfonamide
DE50201028D1 (en) Diarylgelbpigmentpraeparationen
PL368727A1 (en) 17alpha-hydroxy-14beta-steroids with hormonal effect
GB0108861D0 (en) Matchit
EP1355643A4 (en) EPOXYVIBSANIN B
AU2001100134A4 (en) Enviro-trap
GB0115127D0 (en) Wheelarrow
CA93646S (en) Fauteuil
CA93126S (en) Titlt-latch
GB0109830D0 (en) Style-flow
GB0105453D0 (en) Shopaholics
GB0102272D0 (en) Biligands